Reference intervals for high sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide in children and adolescents on the Siemens Atellica

被引:0
作者
Ameh, Akoji [1 ]
Brady, Jennifer J. [1 ,2 ]
机构
[1] Childrens Hlth Ireland Crumlin, Dept Biochem, Cooley Rd, Dublin D12 N512 12, Ireland
[2] Univ Coll Dublin, Sch Med, Dublin 4, Ireland
关键词
Atellica; NT-proBNP; paediatric; reference intervals; troponin;
D O I
10.1515/cclm-2023-0977
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives The cardiac biomarkers high sensitivity cardiac troponin I (hs-cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are utilised in paediatric healthcare for the diagnosis and prognostic assessment of many conditions including myocarditis, congenital heart disease, multisystem inflammatory syndrome in children (MIS-C) and heart failure. However, the standardised age-related reference intervals, 99th percentile cut-offs and clinical guidelines are not available, making the interpretation of these biomarkers challenging. This study aimed to generate normative data in a paediatric cohort for the Siemens Atellica (R) IM 1300 analyser. Methods Residual plasma samples were collected from children aged up to 17 years attending primary care and out-patient settings and with no apparent evidence of cardiac dysfunction, renal dysfunction or other confounders. Reference intervals were generated using the 2.5th-97.5th percentiles, and 99th percentile cut-offs determined according to CLSI EP28-A3c. Results Statistical analysis revealed that partitioning was not required for gender for either biomarker. The reference interval for hs-cTnI for children aged one month to 16 years (n=292, 146 females and 146 males) was <14 ng/L with a 99th percentile cut-off of 19 ng/L. The reference interval for NT-proBNP for children aged one month up to one year was <714 ng/L (n=14) and for children aged 1-16 years (n=339) was <295 ng/L. Conclusions This is the first paediatric reference interval data generated on the Siemens Atellica (R) solution. These reference intervals and 99th percentiles will inform clinical decisions in the paediatric cardiology setting.
引用
收藏
页码:1636 / 1642
页数:7
相关论文
共 50 条
  • [31] N-Terminal Pro-B-Type Natriuretic Peptide as a Marker of Severity of Heart Failure in Children with Congenital Heart Diseases
    Chowdhury, Ritabrata Roy
    Kaur, Satnam
    Gera, Rani
    PEDIATRIC CARDIOLOGY, 2023, 44 (08) : 1716 - 1720
  • [32] N-Terminal Pro-B-Type Natriuretic Peptide as a Marker of Severity of Heart Failure in Children with Congenital Heart Diseases
    Ritabrata Roy Chowdhury
    Satnam Kaur
    Rani Gera
    Pediatric Cardiology, 2023, 44 : 1716 - 1720
  • [33] Cardiac Biomarkers for Monitoring Canine Heartworm Disease: A Comparative Study of N-Terminal Pro B Type Natriuretic Peptide and Cardiac Troponin I Levels
    Asawakarn, Sariya
    Tachampa, Kittipong
    Taweethavonsawat, Piyanan
    THAI JOURNAL OF VETERINARY MEDICINE, 2023, 53 (04): : 503 - 506
  • [34] Relationship between N-terminal pro-B-type natriuretic peptide (Nt-proBNP) and cardiac cycle efficiency in cardiac surgery
    Scolletta, S.
    Ranaldi, G.
    Carlucci, F.
    Franchi, F.
    Romano, S. M.
    Biagioli, B.
    BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (08) : 511 - 515
  • [35] Plasma N-terminal pro-B-type natriuretic peptide concentration in healthy retired racing Greyhounds
    Couto, Kristen M.
    Iazbik, M. Cristina
    Marin, Liliana M.
    Zaldivar-Lopez, Sara
    Beal, Melissa J.
    Gomez Ochoa, P.
    Couto, C. Guillermo
    VETERINARY CLINICAL PATHOLOGY, 2015, 44 (03) : 405 - 409
  • [36] Evaluation of the Efficiency of N-terminal Pro-B-type Natriuretic Peptide for Diagnosis of Acute Myocardial Infarction
    Dafalla, Abuagla M.
    Dafalla, Leena A.
    Ahmed, ShamsEldein M.
    Mohammed, Yousif A.
    Abakar, Adam D.
    Aballah, Wed Elbahar H.
    Ahmed, Elhadi A.
    Modawe, GadAllah
    SUDAN JOURNAL OF MEDICAL SCIENCES, 2020, 15 (03): : 247 - 256
  • [37] Prognosis Implication of N-Terminal Pro-B-Type Natriuretic Peptide in Adult Patients With Acute Myocarditis
    Zhao, Yan
    Lyu, Naqiang
    Zhang, Wei
    Tan, Huiqiong
    Jin, Qi
    Dang, Aimin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [38] N-Terminal Pro-B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure
    Lainchbury, John G.
    Troughton, Richard W.
    Strangman, Kim M.
    Frampton, Christopher M.
    Pilbrow, Anna
    Yandle, Timothy G.
    Hamid, Amjad K.
    Nicholls, M. Gary
    Richards, A. Mark
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 55 (01) : 53 - 60
  • [39] Prognostic value of N-terminal Pro-B-Type natriuretic peptide in patients with intermediate coronary lesions
    Song, Chenxi
    Yuan, Sheng
    Cui, Kongyong
    Cai, Zhongxing
    Zhang, Rui
    He, Jining
    Qiao, Zheng
    Bian, Xiaohui
    Wu, Shaoyu
    Wang, Haoyu
    Fu, Rui
    Wang, Chunyue
    Liu, Qianqian
    Yin, Dong
    Jia, Lei
    Dou, Kefei
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [40] N-Terminal Pro-B-Type Natriuretic Peptide Is Inversely Associated With Metabolic Syndrome in Hypertensive Patients
    Chang, Huai-Ren
    Hsieh, Jen-Che
    Hsu, Bang-Gee
    Wang, Ling-Yi
    Chen, Michael Yu-Chih
    Wang, Ji-Hung
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 348 (03) : 210 - 214